Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-23-004582

Options or other derivatives

  • Head of Pharm Ops and Tech acquired 6,305 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Murphy Nicole Head of Pharm Ops and Tech 2023-02-08 Grant or award · Restricted Stock Unit +6,305 6,305 D
Loading xslF345X03/form4.xml…